418 related articles for article (PubMed ID: 12899550)
1. Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital: a 10-year prospective register of 3,954 patients.
Dahl OE; Gudmundsen TE; Bjørnarå BT; Solheim DM
Acta Orthop Scand; 2003 Jun; 74(3):299-304. PubMed ID: 12899550
[TBL] [Abstract][Full Text] [Related]
2. High incidence of in-hospital pulmonary embolism following joint arthroplasty with dalteparin prophylaxis.
Kerr J; Linkins LA
Thromb Haemost; 2010 Jan; 103(1):123-8. PubMed ID: 20062935
[TBL] [Abstract][Full Text] [Related]
3. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
Bell GK; Goldhaber SZ
Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
[TBL] [Abstract][Full Text] [Related]
4. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
[TBL] [Abstract][Full Text] [Related]
5. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
6. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting.
Ennis RS
J South Orthop Assoc; 2003; 12(1):10-7. PubMed ID: 12735619
[TBL] [Abstract][Full Text] [Related]
7. [Early diagnosis and treatment of pulmonary embolism after total joint replacement: report of five cases].
Guan ZP; Lü HS; Wu C; Sun TZ; Tian J; Kou BL; Yuan YL
Zhonghua Wai Ke Za Zhi; 2003 Jan; 41(1):37-40. PubMed ID: 12760756
[TBL] [Abstract][Full Text] [Related]
8. Assessing the quality of pharmacological treatments from administrative databases: the case of low-molecular-weight heparin after major orthopaedic surgery.
Gerkens S; Beguin C; Crott R; Closon MC; Horsmans Y
J Eval Clin Pract; 2008 Aug; 14(4):585-94. PubMed ID: 18462276
[TBL] [Abstract][Full Text] [Related]
9. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
10. [Low-molecular-weight heparin for preventing deep-vein thrombosis after total joint arthroplasty].
Yang G; Lu H; Gao J; Kou B; Yuan Y; Xu B
Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):25-7. PubMed ID: 11831980
[TBL] [Abstract][Full Text] [Related]
11. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
Lu X; Lin J
BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
[TBL] [Abstract][Full Text] [Related]
12. The incidence of fatal pulmonary embolism after primary hip and knee replacement in a consecutive series of 4253 patients.
Cusick LA; Beverland DE
J Bone Joint Surg Br; 2009 May; 91(5):645-8. PubMed ID: 19407300
[TBL] [Abstract][Full Text] [Related]
13. DVT prophylaxis: better living through chemistry: affirms.
Pellegrini VD
Orthopedics; 2010 Sep; 33(9):642. PubMed ID: 20839678
[TBL] [Abstract][Full Text] [Related]
14. Rationale for thromboprophylaxis in lower joint arthroplasty.
Colwell CW
Am J Orthop (Belle Mead NJ); 2007 Sep; 36(9 Suppl):11-3. PubMed ID: 17948162
[TBL] [Abstract][Full Text] [Related]
15. Frequency and timing of clinical venous thromboembolism after major joint surgery.
Bjørnarå BT; Gudmundsen TE; Dahl OE
J Bone Joint Surg Br; 2006 Mar; 88(3):386-91. PubMed ID: 16498018
[TBL] [Abstract][Full Text] [Related]
16. The ACCP guidelines for thromboprophylaxis in total hip and knee arthroplasty.
Colwell CW
Orthopedics; 2009 Dec; 32(12 Suppl):67-73. PubMed ID: 20201479
[TBL] [Abstract][Full Text] [Related]
17. The effect of mobilisation of patients during treatment of thromboembolic disorders with low-molecular-weight heparin.
Partsch H; Kechavarz B; Köhn H; Mostbeck A
Int Angiol; 1997 Sep; 16(3):189-92. PubMed ID: 9405014
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism prophylaxis after total knee or hip replacement: treatment pattern and outcomes.
Penning-van Beest FJ; Overbeek JA; Meijer WM; Woodruff K; Jackson J; van der Vis H; van der Linden P; Herings RM
Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):972-8. PubMed ID: 21748826
[TBL] [Abstract][Full Text] [Related]
19. [Influence of body mass index and age on deep vein thrombosis after total hip and knee arthroplasty].
Guan Z; Chen Y; Song Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Jun; 20(6):611-5. PubMed ID: 16827383
[TBL] [Abstract][Full Text] [Related]
20. The rationale for long-term prophylaxis of venous thromboembolism.
Agnelli G; Mancini GB; Biagini D
Orthopedics; 2000 Jun; 23(6 Suppl):s643-6. PubMed ID: 10875429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
